Target intelligence / Profile preview

Apolipoprotein B mRNA editing enzyme catalytic subunit 3A pseudogene 1 (APOBEC3AP1)

Target
APOBEC3AP1
Molecular classification
Pseudogene, Processed pseudogene, Non-coding RNA (potentially)
01

Overview

Apolipoprotein B mRNA editing enzyme catalytic subunit 3A pseudogene 1 (APOBEC3AP1) is a processed pseudogene related to the APOBEC3A gene, which belongs to the cytidine deaminase gene family involved in anti-viral immunity and DNA editing*[5][6]*. As a pseudogene, APOBEC3AP1 does not encode a functional protein but may participate in regulation at the RNA level, such as via antisense transcripts, small interfering RNAs, or serving as a competitive endogenous RNA that can modulate gene expression in the genome*[2]*. Like many pseudogenes, APOBEC3AP1 may exert subtle regulatory effects on its parental gene or related pathways and can potentially act as a biomarker for specific disease conditions, although there is currently no direct evidence that it plays a significant disease or therapeutic target role on its own*[2][6]*. Pseudogenes such as APOBEC3AP1 can sometimes influence disease by affecting the expression, splicing, or regulation of related protein-coding genes, especially in cancer and other complex diseases, but are not typical therapeutic targets*[2]*. APOBEC3A (the parental gene) participates in immunity, DNA editing, and has been linked to specific diseases (e.g., cancer), but APOBEC3AP1 itself is not known to have direct pathogenic or therapeutic relevance*[1][5]*.

Other names
Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3A pseudogene 1ABC3AP1(official gene symbol: APOBEC3AP1)
02

Biological functions

Post-transcriptional regulationCompeting endogenous RNA function (regulates parental gene expression via ceRNA, siRNA, or antisense mechanisms)*[2]*Potential involvement in gene expression modulation and genome regulation
03

Disease associations

Potential biomarker (general for pseudogenes, no direct evidence for this gene)Possible involvement in cancer or genetic disease via regulatory effects*[2]*

Beyond the preview

Go deeper on Apolipoprotein B mRNA editing enzyme catalytic subunit 3A pseudogene 1 (APOBEC3AP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apolipoprotein B mRNA editing enzyme catalytic subunit 3A pseudogene 1 (APOBEC3AP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call